Os GLP-1: reduzem a motilidade intestinal alteram o ambiente luminal favorecem algumas bactrias e inibem outras Melhorias possveis aumento de Akkermansia (anti-inflamatria) melhora da barreira intestinal aumento de SCFAs Riscos possveis disbiose transitria diarreia constipao SIBO (supercrescimento bacteriano) Ateno, Nutri: Pacientes que usam GLP-1 + tm dieta pobre em fibras alto risco de disbiose
Semaglutide is primarily sensitive to heat rather than brief cold exposure, but you still want to bring deliveries inside promptly and avoid leaving medication in a vehicle or outdoor mailbox for extended periods
Reported side effects are rare and typically mild: Transient drowsiness or mild fatigue following administration
- If taking medications indicated for control of AD symptoms, on stable doses for at least 8 weeks prior to screening Exclusion criteria - Any history of bipolar affective disorder - A medical condition, other than AD, that may contribute to the individuals cognitive impairment - Stroke or transient ischemic attack in the past 12 months - Clinically significant unstable psychiatric condition in the past 6 months - Inability to swallow oral medications - Other medical conditions which the investigator deems would limit the individuals life expectancy to less than 6 months - Concurrent use of anti-depressant medication - Participation in another interventional clinical trial, or intake of another investigations drug within 4 weeks or 5 half-lives (whichever is longer) Study Estimands Primary estimand 1
GLP-1RAs are contraindicated in pregnant or breastfeeding women, as well as for patients with severe gastrointestinal diseases including pancreatitis, multiple endocrine neoplasia, and medullary thyroid cancer
Or, if youre noticing symptoms, try splitting the daily dose into two parts, taking one in the morning and one in the evening
